🔎 Trials Near Me

首頁 › 非小細胞肺癌 › 密西西比

密西西比 的 非小細胞肺癌 臨床試驗

20 項針對 非小細胞肺癌 的研究正在 密西西比 各地點尋找參與者。

密西西比 的城市

官方研究文本（英文）

A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

  • Hattiesburg Clinic /ID# 248033, Hattiesburg
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年10月5日 · NCT04928846

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

  • Baptist Memorial Hospital and Cancer Center-Golden Triangle, Columbus
  • Baptist Cancer Center-Grenada, Grenada
  • University of Mississippi Medical Center, Jackson
  • 還有 3 項
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年10月5日 · NCT04267848

A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment

  • Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven
招募中2 期
18 歲及以上 · 所有性別 · 更新於 2026年10月2日 · NCT07293247

A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

  • Local Institution - 0180, Hattiesburg
招募中2 期
18 歲及以上 · 所有性別 · 更新於 2026年10月2日 · NCT07680764

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

  • Baptist Memorial Hospital and Cancer Center-Golden Triangle, Columbus
  • Baptist Cancer Center-Grenada, Grenada
  • University of Mississippi Medical Center, Jackson
  • 還有 3 項
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年10月1日 · NCT06498635

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

  • Baptist Cancer Center, Southaven
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年9月28日 · NCT07144280

Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)

  • Hattiesburg Clinic Hematology/Oncology ( Site 0104), Hattiesburg
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年9月25日 · NCT06170788

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

  • Hattiesburg Clinic Hematology/Oncology, Hattiesburg
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年9月25日 · NCT07222566

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

  • Jackson Oncology Associates, PLLC, Jackson
  • Jackson Oncology Associates, PLLC, Jackson
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年9月25日 · NCT06758401

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

  • Research Site, Hattiesburg
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年9月23日 · NCT06357533

A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%

  • Hattiesburg Clinic Hematology/Oncology, Hattiesburg
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年9月23日 · NCT06561386

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

  • Clinical Study Site, Hattiesburg
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年9月18日 · NCT06767514

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

  • Jackson Oncology Associates - The Hederman Cancer Center, Jackson
招募中2/3 期
18 歲及以上 · 所有性別 · 更新於 2026年9月16日 · NCT04613596

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  • North Mississippi Hematology and Oncology Associates, Tupelo
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年9月8日 · NCT06119581

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

  • Baptist Memorial Hospital and Cancer Center-Golden Triangle, Columbus
  • Baptist Cancer Center-Grenada, Grenada
  • University of Mississippi Medical Center, Jackson
  • 還有 3 項
招募中2 期
18 歲及以上 · 所有性別 · 更新於 2026年6月3日 · NCT05642572

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

  • Baptist Memorial Hospital and Cancer Center-Golden Triangle, Columbus
  • Baptist Cancer Center-Grenada, Grenada
  • Baptist Memorial Hospital and Cancer Center-Union County, New Albany
  • 還有 2 項
招募中2 期
18 歲及以上 · 所有性別 · 更新於 2026年5月6日 · NCT06116682

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

  • Baptist Memorial Hospital and Cancer Center-Golden Triangle, Columbus
  • Baptist Cancer Center-Grenada, Grenada
  • Gulfport Memorial Hospital, Gulfport
  • 還有 3 項
招募中2/3 期
18 歲及以上 · 所有性別 · 更新於 2026年5月5日 · NCT06616584

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

  • Baptist Memorial Hospital and Cancer Center-Golden Triangle, Columbus
  • Baptist Cancer Center-Grenada, Grenada
  • Baptist Memorial Hospital and Cancer Center-Union County, New Albany
  • 還有 2 項
招募中2 期
18 Minutes · 所有性別 · 更新於 2026年5月5日 · NCT06031688

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

  • Baptist Memorial Hospital and Cancer Center-Golden Triangle, Columbus
  • Baptist Cancer Center-Grenada, Grenada
  • Baptist Memorial Hospital and Cancer Center-Union County, New Albany
  • 還有 2 項
招募中觀察性研究
18 歲及以上 · 所有性別 · 更新於 2026年3月17日 · NCT06418204

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Hattiesburg
招募中觀察性研究
所有年齡 · 所有性別 · 更新於 2025年10月28日 · NCT03452774

資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。